ology-technology.asp <a href="http://feeds.bio-medicine.org/latest-biology-technologyDate:7/7/2008">http://feeds.bio-medicine.org/latest-biology-technologyDate:7/7/2008</a> ies a total equity value for API of $625 million, assuming $75 million in cash and cash equivalents at API at closing and no debt, other than the guarantees of the remaining amounts of Angiotech's two existing debt issues.